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ABSTRACT

Myoglobin (Mb) and Myoglobin-H (Mb-H) react with glycerophosphocholine (GPC) lipid in
the presence of oxygen. This reaction allows the heme group in the protein the chance to
induce peroxidation reactions with the lipid. Several aldehyde products of this type of
reaction with arachadonic acid have previously been determined, with Mb generating greater
quantities of aldehyde products than Mb-H. The focus of this research was to establish the
presence of some products from the reactions of Mb and Mb-H with GPC (which contains
arachadonic acid) that are more prevalent from Mb-H than Mb, or that only form from the
reaction of Mb-H with GPC. A combination of spectrophotometry, TLC, and ion-trapping
GC-MS was used to establish the generation of an oxidation product of arachidonic acid
metabolism that is generated in larger quantities by the reaction of Mb-H with GPC than by
the reaction of Mb with the same lipid.
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CHAPTER 1
INTRODUCTION
1.1.

Introduction to Myoglobin
The structure of myoglobin (Mb) was first determined by high-resolution x-ray

crystallography in 1958 by John Kendrew and associates.1 This discovery resulted in
Kendrew sharing the 1962 Nobel Prize in Chemistry.2 Figure 1.1 depicts the tertiary
structure of Mb: a 16,700 Dalton globular protein made up of a single polypeptide chain
consisting of 154 amino acids. At the center of the eight alpha helixes (purple) that make up
myoglobin is an iron-containing porphyrin, the heme prosthetic group (grey). Oxygen
reversibly binds to the heme group of Mb, which stores oxygen, acts as a buffer for the
partial pressure of oxygen, and facilitates oxygen diffusion.3

Figure 1.1. Tertiary Structure of Myoglobin

1.2.

Introduction to Rhabdomolysis
Rhabdomyolysis is the disintegration of skeletal muscle fibers, resulting in the release

of Mb into the bloodstream. There are several causes of muscle injury that result in
rhabdomolysis, including major trauma, drug toxicity, infections such as HIV and influenza,
severe exertion, and alcoholism.4 There are two types of causes of rhabdomyolysis: those that
are inherited and those that are acquired. Examples of inherited disorders include
deficiencies in carbohydrates and fatty oxidation enzymes. Examples of acquired disorders
that induce the breakdown of muscle include tissue crush and ischemia, a restriction of blood
supply.5 Rhabdomyolysis results in the leakage of the muscle contents into the surrounding
areas and possibly myoglobinuria, or excess Mb in the urine.
Myoglobinuria was first associated with the toxicity leading to acute renal failure
during The Battle of Britain of World War II.6 More recently, it has been noted in substance
abuse and drug overdoses.7 In severe cases of myoglobinuria, this condition can lead to acute
renal failure.6 The release of Mb from skeletal muscle is believed to cause renal
vasoconstriction, obstruct the renal tubules, and cause renal cytotoxicity associated with lipid
peroxidation within the tubular cells.8
When muscular tissue is damaged, intravascular fluids accumulate in the space
created as the cells undergo necrosis causing hypovolemia, or a low volume of blood.
Hypovolemia activates the sympathetic nervous system and the rennin-angiotensinaldosterone system to produce vasoconstricting molecules and to limit the production of
vasodilators. Myoglobin acts to degrade NO, a major vasodilator in the body. The overall
increase in vasoconstrictors along with the decrease in vasodilators leads to renal
vasoconstriction.9 Renal tubular obstructions known as myoglobin casts form from
2

precipitated myoglobin that is filtered through the glomerulus. The myglobin is deposited in
the lumen and causes occlusion as the myoglobin concentrates due to the tubular
reabsorption of water.7,9
1.3.

Modifications of Myoglobin
When myoglobin is allowed to react with H2O2, covalent modifications to the

hemoprotein occur. As described in Figure 1.2, the three pathways of covalent modification
are hypothesized to end with either a covalent alteration on the heme, a covalent alteration on
the protein, or a crosslink between the heme and the protein.10

Figure 1.2. Pathways for the Covalent Modification of Hemoproteins.10
The crosslinking of the heme to tyrosine residue 103 results in the protein-bound heme
adduct of myoglobin (Mb-H) (Figure 1.3).10

3

Figure 1.3. Transformation of Myoglobin to an Oxidase.10
Radioactive labeling was used to determine that up to 88% of the product of this reaction is
Mb-H. It was also demonstrated that within an hour of loading Mb-H into human fibroblasts,
40% of the cells would exhibit cell death, whereas loading of myoglobin or external exposure
to Mb-H did not show an increase in cell death compared to untreated cells. Incubation of
the cells with N-acetyl-L-cysteine, butylated hydroxytoluene, and extracellular catalase
inhibited the toxicity of Mb-H. This indicates that oxidative stress is a contributing factor in
Mb-H toxicity.10
1.4.

Lipid Peroxidation
Cytotoxicity is associated with the release of Mb during rhabdomyolysis. One major

consequence of Mb toxicity is lipid peroxidation. The heme center of Mb is thought to

4

undergo redox cycling between ferrous, ferric, and ferryl oxidation states, which activates
oxygen.
Oxygen species with unpaired electrons form a type of free radical known as reactive
oxygen species (ROS). When a ROS encounters a cellular membrane, it can initiate a chain
reaction known as lipid peroxidation by stealing an electron (often in the form of hydrogen to
form water) from the membrane lipids. This results in a lipid radical, a lipid with an unpaired
electron. Lipid radicals are very unstable and likely to react with molecular oxygen to
generate peroxyl fatty acid radicals. In turn, a peroxyl fatty acid will react with another free
lipid to create a hydrogen peroxide and a different lipid radical, which will propagate the
peroxidation reaction by reacting with another lipid. The new lipid will continue the cycle,
generating more free radicals. The chain reaction is terminated when the radicals are
scavenged by the body’s antioxidants. Figure 1.4 shows the peroxidation cycle and some of
its products.

Figure 1.4. Lipid Peroxidation. The lipid peroxidation cycle starts with a polyunsaturated
fatty acid. Throughout the cycle of peroxidation, several products and intermediates are
5

formed, including conjugated dienes, isoprostanes, monohydroxylated fatty acids, lipid
hydroperoxide and aldehydes. The various methods of analytical detection of these products
are noted in red alongside the products they detect. Definitions of all acronyms can be found
in Appendix A.

One of the main cellular polyunsaturated fatty acids attacked by ROS is arachidonic
acid, which contains 20 carbon atoms and four double bonds. Glycerophospholipids contain
fatty acids such as arachidonic acid attached to the first two carbons of a glycerol backbone
and a charged or polar group attached to the third carbon via a phosphodiester linkage.
Glycerophosphocholine (GPC) has a positively charged choline attached to the third carbon
of the glycerol backbone. Figure 1.5 depicts GPC, where R1 and R2 represent fatty acids,
such as arachidonic acid.

Figure 1.5. Glycerophosphocholine. Glycerophosphocholine has a glycerol backbone with
a charged choline at the third Carbon; R1 and R2 represent fatty acids such as arachidonic
acid.

6

The oxidation of arachidonic acid by reactive oxygen species also leads to the
formation of F2 isoprostanes, which are not breakdown products of arachidonic acid, but
rather molecules that have a structure very similar to that of naturally occurring molecules
known as prostaglandins.11 The F2 isoprostanes are known to be potent renal
vasoconstrictors, and patients with rhabdomyolysis are often found to have F2 isoprostanes
in the kidneys and urine.12 The many pathways of enzymatic and non-enzymatic (i.e. lipid
peroxidation) oxidation of arachidonic acid are shown in Figure 1.6.
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Figure 1.4.3 Pathways of Arachadonic Acid Oxidation.
Several pathways of Arachadonic Acid Oxidation are shown. Several assays are used to
Figure
Arachidonic
Acidproducts
Oxidation
detect1.6.
bothPathways
enzymaticofand
non-enzymatic
of lipid peroxidation.
Conjugated dienes such as arachidonic acid are an oxidized intermediate of
polyunsaturated fatty acids (PUFAs), which are produced by hydrogen atom abstraction and
migration of double bonds so that they are separated by a single bond. This molecular
8

feature allows for UV (Ultra Violet) detection of conjugated dienes. These can be detected at
a wavelength of 233 nm. Unfortunately, other compounds are also known to absorb light at
the same wavelength, which leads to some inconsistencies in using the assay for conjugated
dienes as a means to detect lipid peroxidation products.
Lipid hydroperoxides and peroxidase activity can also be detected by
chemiluminescence assays in combination with separation techniques such as HPLC and
SDS-PAGE.13 Oxidation of isoluminol by hydroperoxides emits light that allows the
distinction between plasma hydroperoxides from cholesterol esters and phospholipids.
Immunochemical techniques are also used to detect hydroperoxides. For example, in the
iodometric assay iodide reacts with hydroperoxides to form iodine or triiodide. The
thiobarbituric acid reactive substance (TBARS) assay is nonspecific, and typically the
thiobarbituric acid reacts with substances like malondialdehyde; the products absorbs at 532
nm and fluorescence at 532 and 553 nm. The ferrous oxidation-xylenol orange (FOX) assay,
also nonspecific, utilizes xylenol orange to bind to the ferric ions and produces colored
complexes with absorbance at 560 nm.14
Several aldehyde products of lipid peroxidation can be determined with GC and
HPLC assays.15 These aldehydes include hexanal, malondialdehyde, and 4-hydroxynonenal.
In previous studies, the formation of lipid peroxidation products like hexanal, 4hydroxynonenal, and malondialdehyde from the peroxidation of arachidonic acid by Mb and
Mb-H were examined using GC assays.
GC/MS, thin layer chromatography (TLC) and high pressure liquid chromatography
(HPLC) have all been used to look at non-aldehyde products of lipid peroxidation of PUFAs.
GC/MS has been used to detect peroxidation products such as isoprostanes and

9

monohydroxylated fatty acids.16 Thin layer chromatography (TLC) has been used to separate
products of lipid peroxidation followed by detection using a reaction with certain acids.
Scraping of the TLC plate followed by solid phase extraction has been used to allow further
analysis of the material of interest.17 HPLC has been used to separate peroxidation products
using various detection methods including mass spectrometry and UV detection.14
1.5.

Review of the Literature
In 1996, Drs. Osawa and Williams examined the toxicological effects of treatment of

myoglobin with H2O2. It was known that treating myoglobin with H2O2 resulted in covalent
modification of the heme group to the protein. However, the exact nature and the
toxicological effects of these adducts were not well defined. When considering the covalent
modification of heme proteins, there are three possible pathways that exist: the heme is
altered, the protein is altered, or the heme crosslinks to the protein. The alteration of the
heme and the alteration of the protein are both well studied and well documented. Osawa
and Williams chose to study the crosslinking of the heme to protein. This crosslinking was
previously structurally defined in two situations; both resulted in the transformation of the
myoglobin protein to an oxidase. The first case involves the histidine residue 93 of
myoglobin as a result of treatment with CBrCl3. The complete structure of the adduct in this
case has been fully defined. The second case utilizes treatment of myoglobin with H2O2; this
involves the tyrosine residue 103 of myoglobin. The complete structure of this adduct had
yet to be established, so they focused their study on developing a better understanding of this
adduct and the toxicological implications of its formation. 10
Of these two crosslinking pathways, the H2O2 treatment was supposed to account for
about 18% of the heme, based on the amount of chromophore associated with the protein
10

after extractions. The CBrCl3, on the other hand, was previously shown to account for about
60% of the heme, based on radioactive-labeling. Osawa and Williams utilized radiolabeling
to establish that up to 88% of the heme was altered during reactions with H2O2. They were
also able to demonstrate that upon introduction of the covalently altered myoglobin into
human fibroblasts the cells would die. One hour after fibroblast cells were loaded with a
partially purified protein-bound heme adduct, 40% of the cells exhibited cell death. Cells
loaded with apomyoglobin or myoglobin exhibited only minimal toxicity, as did cells treated
extracellularly with the protein-bound heme adduct. This was an indication of potential
toxicological effects of covalently altered myoglobin and suggested important implications
for the oxidative injury in cells containing large amounts of myoglobon. Incubation of the
cells with either N-acetyl-L-cysteine, butylated hydroxytoluene, or extracellular catalase
prior to loading of the protein-bound heme adduct inhibited toxicity by nearly 50%, 40%, and
28%, respectively. This indicated a mechanism that involved oxidative stress. 10
In 1998, Drs. Osawa and Vuletich developed an assay for rapid, sensitive, and
efficient detection of protein-bound heme adducts. The protein-bound heme adducts of
myoglobin had not only been shown to act as a biomarker for oxidative damage but also had
been shown to act as a peroxidase. Utilizing a combination of the peroxidase activity,
standard electrophoresis methods, and enhanced chemiluminescence, Osawa and Vuletich
were able to develop a sensitive method for the detection and quantification of these proteinbound heme adducts. There were certain conditions that had been established under which
the native heme of myoglobin completely dissociated from the protein during
electrophoresis. This was used to quantify the protein-bound heme adduct by enhanced
chemiluminescence in samples that contained mixtures of heme products. 13 In this method,
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SDS-PAGE was utilized to remove the native heme prosthetic group from myoglobin,
leaving only the protein-bound heme adduct. Thiol reducing agents such as dithiothreitol
interfere with the peroxidase detection of myoglobin by causing a decrease in peroxidase
activity and the deterioration of both the heme and the protein-bound heme adduct during
sample preparation. The formation and degradation of this adduct during sample preparation
and analysis determined the amount of Mb-H present. In this study, Osawa and Vuletich
were able to demonstrate that the thiol reducing agent tris(2-carboxyethyl)phosphine
hydrochloride did not lead to the degradation of the protein bound heme adduct or the heme
itself; rather it seemed to stabilize the Mb-H during electrophoresis so the peroxidase signal
was actually enhanced. Tris(2-carboxyethyl)phosphine hydrochloride was compatible with
the enhanced chemiluminescence assay used in the study. It was believed that this method
could be used to map active sites of the hemoprotein, to help discover new hemoproteins, and
to define heme-binding subunits of hemoproteins. 13
In 2000, Osawa, Vuletich, and Aviram determined the role of the protein-bound heme
in lipid oxidation. It was known that the crosslinking of the heme to the protein involved an
active site on a tyrosine residue.10 Upon the formation of the protein-bound heme adduct,
myoglobin was transformed from an oxygen storage protein to oxidase catalyzing enzyme.
The protein-bound heme adduct of Mb-H catalytically forms hydrogen peroxide which
perpetuates the formation of more Mb-H, making the process self-sustaining. In trying to
better understand the toxicity associated with the reaction of myoglobin and Mb-H with
peroxides, the oxidation of low density lipoproteins (LDL) and purified lipids by Mb-H were
studied. The fatty acids in the LDL were oxidized by both Mb-H and native myoglobin;
however, Mb-H was shown to oxidize seven times as much lipid as Mb. Both the formation
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of lipid peroxides and the TBARS assay were used to demonstrate a concentration-dependent
increase in LDL oxidation after incubation of LDL with Mb-H as shown in Figure 1.7A. 18

Figure 1.7. LDL Oxidation by Mb-H. (A) Study of purified LDL incubated with various
concentrations of Mb-H for 2 hours at 37ºC, then assayed for lipid peroxides (circles) and
TBARS (squares). (B) A time-course study of purified LDL incubated with and without MbH, alliquots of 1mL were assayed for conjugated diene formation.18
Conjugated dienes also increased after an initial lag period of about 30 minutes, as
shown in Figure 1.7B. Lipid peroxides were also shown in Figure 1.8 to form from Low
Density Lipoprotein (LDL), palmitoyl arachidonyl phosphatidylcholine (PAPC), and
cholesteryl arachadonate (CA). PAPC is composed of glycerophosphorylcholine containing
the fatty acids palmitate and arachidonate. Although the three substrates form in equal
quantities, the TBARS assay indicated slightly less lipid peroxides were formed with CA
than with the LDL or PAPC.18

13

Figure 1.8. Mb-H Induced Phospholipid and Cholesteryl Ester Oxidation.18 Low Density
Lipoprotein (LDL), Palmitoyl Arachidonyl Phosphatidylcholine (PAPC), and Cholesteryl
Arachidonate (CA) were independently incubated with and without Mb-H for 2 hours at 37C.
(A) Lipid peroxide formation after 2 hour incubation. (B) TBARS formation after 2 hour
incubation.18
The formation of conjugated dienes was used to compare PAPC oxidation by Mb,
Mb-H, and apo-Mb; data are shown in Figure 1.9. The rate of conjugated diene formation
from equal concentrations of protein demonstrated Mb-H to be the most effective of the
substrates, specifically looking at formation during the first five minutes of reaction.18

14

Figure 1.9. PAPC Oxidation.18 Time-course reactions of PAPC with Mb-H (closed
squares), Mb (open triangles), apo-Mb (closed circles), and a control with no protein (open
squares). Aliquots were assayed for conjugated diene formation from 4 replicate studies.17
The Mb-H preparation actually contained a large amount of apo-Mb, so
demonstrating that apo-Mb has a slower rate of conjugated diene formation served to indicate
that Mb-H catalyzed the oxidation of PAPC. 18
1.6.

Significance of the Project
The purpose of this study was to examine the reactions of myoglobin and myoglobin-

H with arachidonic-containing lipids in search of a product that can serve as a biomarker for
these lipid peroxidation reactions. If we can demonstrate the existence of a product and show
its formation to be more prevalent in the presence of either Mb or Mb-H, then we can start to
have a better understanding of what to look for when dealing with rhabdomyolysis and tissue
crush injuries.

15

EXPERIMENTAL PROCEDURE
2.1.

Preparation of Oxidation Reactions
A 200-L aliquot of glycerophosphatidyl choline containing arachidonic acid (GPC)

lipid, 400 L of Chelex-treated distilled, deionized water (dH2O), and 200 L of 0.5 M
sodium acetate buffer (pH 6.0) were combined in a test tube and allowed to equilibrate at
37°C for 3 minutes. 200 L of a 5.7 mg/mL solution of Mb or Mb-H was then added to the
test tube, and the reactions were allowed to progress in the presence of oxygen at 37°C with
shaking for 0, 7, 15, or 30 minutes. The tubes were then plunged into ice and the reactions
were quenched with 200 mL of methanol. The organic layer was extracted three times with
500 mL of ethyl acetate.
Blank samples were prepared in the same manner as the samples using 600 L of
Chelex-treated ddH2O, 200 L of GPC lipid, and 200 L of 0.5 M (pH 6.0) sodium acetate
buffer. The proteins were omitted from the blank samples. Negative controls were also
prepared using the same procedure. These samples were prepared using 600 L of Chelextreated dH2O, 200 L of 5.7mg/mL Mb or Mb-H, and 200 L of 0.5 M sodium acetate buffer
(pH 6.0), but no lipid. The oxidation reaction components are summarized in Table 2.1.

16

Table 2.1. Reaction Components

Components

Mb
Reactions
(µl)

Mb-H
Reactions
(µl)

Blank/ Positive
Control
Reactions (µl)

Negative
Control
Reactions (µl)

GPC

200

200

200

0

Mb

200

0

0

Mb-H

0

200

0

0.5 M pH 6.0 Sodium
Acetate Buffer

200

200

200

200

ddH2O

400

400

600

600

Total Volume

1000

1000

1000

1000

200 (of either
protein)

2.2 Conjugated Diene Assay
Samples were dried under nitrogen (N2) gas and re-suspended in 1 mL of
cyclohexane before using a UV-VIS spectrophotometer (Shimadzu/UV-1650PC/2.0 nm slit
width) to determine the presence of conjugated dienes. The absorption spectrum from 200
nm to 500 nm was recorded; conjugated dienes are detected as a broad band in this region
with a maximal absorption at 233 nm.19
2.3 Reduction of lipid hydroperoxides with TPP
The solvent was evaporated under nitrogen gas, and the samples were re-suspended in
1 mL of ether. A 100-L aliquot of 5 mg/mL triphenylphosphine (TPP) in ether was added
to each sample. The samples were allowed to react for 40 minutes at room temperature to
reduce peroxides to alcohols.
17

2.4 Saponification of phospholipids
The samples were dried under nitrogen gas. A 2-ml aliquot of 1 M KOH in methanol
and 2 mL of deionized, distilled H2O (ddH2O) were added to each sample before argon gas
was used to displace any oxygen from the tubes. The tubes were capped and then incubated
for 90 minutes at 80°C before being put on ice. While on ice, 2 mL of ddH2O was added to
each sample, and 2 M HCl was added drop-wise to bring the pH of each sample solution to 3.
Each of the samples was extracted using 1 mL of ethyl acetate:ether solution (1:10 v/v) three
times. A minimal amount of anhydrous sodium sulfate was used as a drying agent to remove
any water from the samples. Each sample was then transferred to a new tube with ethyl
acetate and dried under nitrogen gas. Samples were re-suspended in 200 L of ethyl acetate.
2.5 Thin Layer Chromatography resolution of lipid analytes
For each sample, a 15-L aliquot was spotted onto one thin layer chromatography
(TLC) plate, and the remainder was put on a second TLC plate. The plates were run
simultaneously in a solvent system of hexane:ether:acetic acid (45:5:0.5 v/v/v). The spotted
plate was allowed to dry before it was sprayed with phosphomolybdic acid to identify the
two retention factor (Rf) values of the compounds of interest. A 1 cm band correlating to the
Rf value of the compound was scraped from each plate. The compound of interest was
extracted from the scraped silica using 1.0 mL of ethyl acetate, followed by extraction twice
with 0.5 mL of ethyl acetate in preparation for analysis by GC/MS.
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2.6 Derivatization of lipid analytes
Samples designated for GC/MS were dried under N2 gas and then derivatized prior to
injection onto the column using methods for methyl esters, oximes, and BSTFA (N,Obis(trimethylsilyl) trifluoroacetamide). The methyl ester derivative was formed by first
adding 350 mL of 20% methanol in acetone to each sample followed by 100 mL 0.02 M
trimethylsilyldiazomethane (TMSD) in heptane. The sample tubes were capped and wrapped
in aluminum foil to block light. They were agitated for 1 minute, incubated at room
temperature for 15 minutes, agitated for 1 minute, incubated at room temperature for 15
minutes, agitated for 1 minute, and then dried under nitrogen gas. The oxime derivative was
then formed by adding 50 mL of methoxylamine HCl in dried pyridine (2% wt/vol) to each
sample. The samples were capped, agitated for 1 minute, incubated at 60oC for 90 minutes,
and then dried under nitrogen gas. The BSTFA derivative was prepared by adding 25 L of
dried pyridine followed by 100 L of BSTFA. Samples were capped, agitated for 1 minute,
incubated at 65oC for 60 minutes, and then dried under nitrogen gas. Once the derivatives
had been prepared, the samples were re-suspended in 200 L of ethyl acetate and loaded onto
SepPac C18 solid phase extraction columns. The sample tubes and columns were rinsed
twice with 100 L of methyl formate.
2.7 Ion Trapping GC/MS of lipid analytes
The samples were dried under nitrogen gas and then re-suspended in 100 L of ethyl
acetate for injection onto a Varian GC 3800 Gas Chromatograph (GC) coupled to a Saturn
2200 ion trap mass spectrometer (MS). A non-polar VF-5ms 30M x 0.25mm, 0.25 ID
capillary column with 5% phenylmetholpolysiloxane phase was used. The injector
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tmperature was at 250ºC, and the column flow was set to 1.2 mL/minute. The oven program
had a 2-minute hold at an initial temperature of 200ºC, followed by a 40ºC/minute ramp to
240ºC. It then ramped at 8ºC/minute to 275ºC, where it was held for 7.62 minutes. A 2-L
aliquot of each sample was injected onto the GC column. Each sample was analyzed twice,
first using chemical ionization, then using electron impact ionization, for molecular
fragmentation. Ethyl acetate was used to rinse the system between sample runs.
2.8 Standards
Standard reference materials were prepared for analysis by GC/MS using the same
derivatization and analysis procedures as for the samples. The standards tested included 5
L of 1a,1b-dihomoprostaglandinF2 in methyl acetate (1 mg/100 mL) diluted to 100 L
with ethanol, 10 L of 8-iso PGE2 in ethanol (1 mg/mL), 100 L of 2,3-dinor-11b-PGF2
in ethanol (1 mg/10 mL), 50 L of thromboxaneB2 in ethanol (1 mg/mL), 50 L of 2,3dinor-8-iso PGF2 in methyl acetate (1 mg/10 mL), 50 L of 2,3-dinor PGE1 in ethanol (1
mg/10 mL), and 10 L of PGF2 methyl ester in methyl acetate (1 mg/100 mL).

20

RESULTS AND DISCUSSION
3.1 Conjugated Diene Results
The conjugated diene assay was performed to establish a time course for the
formation of conjugated dienes in the presence and absence of protein oxidants and
oxidizable lipid, palmitoyl arachidonyl phosphatidylcholine (PAPC), hereafter known as
GPC. A control mixture, which is referred to as the “GPC blank,” contained sodium acetate
buffer, GPC lipid, but no protein. This blank was created to determine the extent to which
conjugated diene formation occurred in the absence of Mb or Mb-H. Another control
contained sodium acetate buffer, and either Mb or Mb-H, with no GPC lipid. This negative
control was evaluated to determine whether any conjugated diene formation occurred with
either protein, but in the absence of lipid. In samples containing the complete system
containing lipid and proteins, Mb or Mb-H were allowed to react with the lipid to establish
the time course of conjugated diene formation for each protein. Test reactions were done
with the GPC blank or with solutions containing Mb or Mb-H for 0, 7, 15, and 30 minutes.
The negative controls containing protein but no lipid were allowed to react for 15 minutes.
For all spectra, the absorbance at 500 nm was subtracted from the entire spectrum to
normalize the spectra, thereby giving all samples the same background level. The absorption
band of interest with a peak at 233 nm served as an identifier of the conjugated diene. Figure
3.1 shows results from the 15-minute reactions that were averaged and normalized.
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Figure 3.1. Fifteen Minute Conjugated Diene Assay, Averaged and Normalized.
Conjugated diene assay results for 15 minute Mb (
minute GPC Blank (
control Mb-H (

), 15 minute Mb-H (

), 15 minute negative control Mb (

), 15

), 15 minute negative

).

A vertical line at 233 nm shows the wavelength used to assess conjugated diene
formation. The Mb, Mb-H, and GPC blank all show some indication of conjugated diene
formation. Mb has the highest absorbance, followed by Mb-H, and then the GPC Blank.
Both of the negative controls with protein but not lipid indicate negligible formation of
conjugated diene.
Although the presence of conjugated dienes can indicate the presence of lipid
peroxidation products, this assay is non-exclusive in that other compounds can cause
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absorbance at 233 nm. The negative controls demonstrate the absence of conjugated dienes
because they have minimal absorption around 233 nm. This indicates that the protein alone
is not responsible for the conjugated dienes and that a lipid must be present for these
reactions to take place.
The raw data from the time-course reactions was used to calculate the extent of
conjugated diene formation as the difference between the absorption maximum at 233 nm
and the absorbance corresponding to the isosbestic point at 500 nm. Mb increased the level
of conjugated dienes in the presence of GPC when compared to the level produced with GPC
alone at the 7, 15, or 30-minute time period. On the other hand, Mb-H had a minimal effect
on the conjugated diene level at 7 and 30 minutes with GPC when compared to GPC alone,
and a relatively small increase at 15 minutes. Figure 3.2 summarizes the time-course
reactions of Mb, Mb-H, and GPC blank. Also included are results from the 15-minute
reactions for the negative controls containing Mb or Mb-H but no lipid. As anticipated, these
samples generate a negligible absorbance band at 233 nm.
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Figure 3.2. Summary of time course of conjugated diene formation in the absence or
presence of GPC and protein oxidants. Time course reactions for Mb (
), GPC Blank (

), Negative Control Mb (

), Negative Control Mb-H (

), Mb-H (
) are shown.

The absorbance at 233 nm was normalized for the reaction times of 0, 7, 15, and 30
minutes for the GPC lipid reactions with and without protein. All time course reactions
indicated some conjugated diene formation with the Mb reaction, with GPC indicating the
largest production of conjugated diene. Negative controls containing Mb and Mb-H in the
absence of lipid are shown at 15 minutes, indicating minimal conjugated diene formation. In
summary, the conjugated diene data indicates that there is a difference in the extent to which
Mb and Mb-H induce lipid peroxidation, so it will be of interest to determine whether there is
also a difference in the type of oxidized arachidonic acid metabolite produced by Mb and
Mb-H.
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3.2 Thin Layer Chromatography
Thin layer chromatography was used for preliminary evaluation of the types of lipid
products generated by incubation of Mb or Mb-H with arachidonic acid-containing GPC
(PAPC). A TLC plate was run for each sample as a means of separating out the components
of interest. These components responded to the mobile phase in a way expected of oxidized
products of arachidonic acid forming a band along the top, hereafter indicated as the Top
Spot, and a second band slightly lower than the first band referred to as the 2nd Spot. Figure
3.2 depicts a TLC plate with a Top Spot and a 2nd Spot. In this case, the material spotted on
the plate is the incubation of Mb-H with PAPC in buffer. Unreacted arachidonic acid runs
near to the origin and is observed as a small, faint spot. The size of the Top Spot and 2nd
Spot were considerably smaller in size in negative controls, which contained the lipid but did
not contain Mb or Mb-H.

Figure 3.3. A TLC Plate of Extracts from a Reaction of
Mb-H with GPC. An example of a typical TLC plate
with 2 spots of interest: a Top Spot and a 2nd Spot.
Unreacted arachidonate is observed as a small, faint spot
just above the origin.
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Using TLC as a primary means of separation, it was possible to enrich a preparation
for a subset of reaction products that could then be more easily studied by Gas
Chromatography/Mass Spectrometry (GC/MS).

3.3 GC/MS Chromatograms and Spectras
Figure 3.4 shows a gas chromatogram of the top spot isolated from a 15-minute Mb
reaction with the GPC PAPC after preparation with the reagents used to chemically modify
the lipid products prior to analysis by GC/MS. The chromatogram displayed a predominant
peak at about 7.5 min and a somewhat lesser peak at 5.5 min. The chromatogram was not
monitored beyond 15 min, so it is possible that peaks representing other compounds may
have eluted after the end of this monitoring period. However, the focus of the attention was
the major peaks generated at about 7.5 min, since this was the region used in prior work was
focused on characterization of prostaglandin E2.20
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Figure 3.4. Chromatogram for a 15 min reaction of Mb with GPC. A typical
chromatogram for the incubations of GPC with Mb.
Figure 3.5 shows the chromatogram obtained from analysis of the top spot from 15minute reactions of the glycerophosphatidyl choline PAPC with Mb, Mb-H, or no protein
after treatment with derivatizing reagents and analysis by GC/MS. The overlay of the three
chromatograms gives a more convenient means of qualitatively and semi-quantitatively
comparing the reaction products isolated in the top spot of the TLC for the three reactions.
All three of the chromatograms have prominent peaks that are detectable at 5.5 and 7.4
minutes.
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Figure 3.5. Chromatogram for 15 min reactions of Mb, Mb-H, and a Blank with GPC.
The overlaid chromatograms demonstrate the consistency of specific peaks generated by the
incubation of GPC with and without protein.

Figure 3.6. depicts the mass spectrum from the 7.4-minute peak of the top spot
obtained from the 15-minute Mb reaction. The prominent fragments above an m/z of 200
were 247, 249, 331, 455, and 512.
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Figure 3.6. Mass Spectra for the ‘Top Spot’ of the 7.4-Minute Peak of the 15-Minute
Reaction of Mb with GPC.
Figure 3.7 shows overlaid gas chromatograms of the standards 8-iso-PGE2,
prostaglandinB2, thromboxaneB2, and 8iso-15keto prostaglandin2, all of which produce a
chromatogram with a prominent peak at approximately 7.4 minutes.
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Figure 3.7. Overlaid chromatograms for the derivatized standards 8-iso-PGE2,
prostaglandinB2, thromboxaneB2, and 8-iso-15-keto prostaglandin2alpha. The peak at
7.4 min is prominent for these standards.

Figure 3.8 depicts the mass spectrum associated with the chromatographic peak for
the 7.4 minute peak for 8-iso-15-keto-prostglandin2alpha. The m/z fragments in descending
order of abundances are 279 > 512 > 455 > 391. The same m/z fragments are present in the
7.4-min peak in the chromatogram for the incubated Mb sample, although the relative
abundances of the 512, 455, and 391 m/z fragments are different.
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Figure 3.8. Mass Spectra for the derivatized standard 8-iso-15-keto-prostaglandin2a.
The m/z fragments of 279, 391, 455, and 512 are all prevalent.
The mass spectra for the derivatized standards 8-iso-PGE2, prostaglandinB2, and
thromboxaneB2 were all similar to the spectra for 8iso-15keto prostaglandin2a shown in
Figure 3.8. The same m/z fragments show up in all of the standards, as well as the reactions
of protein with the PAPC lipid.
Areas for the 7.4 min peak of the top spot obtained from the TLC plate from 0
minutes, 15 minutes, and 30 minutes were compared for Mb, Mb-H and a blank reaction in
Figure 3.9. All three reactions gave a relatively low level of the 7.4-min peak at zero time,
which did not greatly increase after 15 min. Interestingly, the 7.4-min peak for the blank
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containing PAPC but no protein was no greater than that for the zero time or 15-min peak,
but 7.4-min peak for the reaction containing Mb or Mb-H was significantly above
background levels.

Figure 3.9. Time course reaction of GPC with Mb, Mb-H, and a Blank. The peak area of
the 7.4 min peaks were determined and plotted for 0, 15, and 30 minutes. Mb-H has the
largest peak area after 30 minutes, indicating a higher amount of product of interest produced
by Mb-H (

) than Mb (

) or the Blank (

) reactions.
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CONCLUSIONS
4.1 General Conclusions
The data in this study stand in contrast to that originally obtained by Osawa et al.,17
where conjugated diene formation occurred to a much greater extent with Mb-H than with
Mb, which suggested that Mb-H stimulates lipid peroxidation reactions that produce alkanes
and oxidized fragments of arachidonate or isoprostanes. Although the experimental
conditions were consistent for the 2 studies, the opposite result was obtained in the present
study, with Mb producing greater levels of conjugated dienes than with Mb-H or in control
reactions with no protein. When either of the proteins was incubated in buffer in the absence
of the protein, a relatively small absorption band with a peak at 233 nm was generated,
suggesting that the products of interest are coming from the breakdown of lipids.
Unfortunately, attempts to use the TBARS assay in the present study (data not presented) to
confirm the production of lipid peroxidation did not yield reliable data.
Given the finding that breakdown products of lipid peroxidation did not apparently
result from Mb-H incubation with PAPC, an attempt was made to determine whether 20carbon oxidation products of arachidonic acid could alternatively be produced. The putative
products of the GPC-containing reactions that were more polar than the fatty acid
components (palmitate and arachidonate) of the phospholipid used in the study were isolated
from the TLC plate using solid phase elution techniques. Whereas two spots were revealed
during the TLC analysis, only the spot associated with the more polar analytes, i.e. the Top
Spot, was characterized. The spots generated from the Mb or Mb-H reactions were
considerably larger than that produced during reactions in the absence of the proteins. These
products where derivatized and analyzed using GC/MS.
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Prominent peaks at 5.5 and 7.4 min were identified in the chromatogram of the
derivatized products obtained from the TLC “top spot” prepared from reactions containing
Mb, Mb-H or no protein. Several prostaglandin standards were used in an attempt to identify
the putative products of the arachidonyl fatty acid. Unfortunately, none of the standards were
characterized by NMR, so the structures of the putative derivatives were not confirmed.
Theoretically, the mass spectra of the structurally dissimilar derivatized lipid products should
yield dissimilar mass spectrum fragmentation patterns, yet the mass fragmentation pattern of
the 7.4-min peak were qualitatively similar. Given these results, it is difficult to conclude
that these analytes were derived from arachidonic acid and to determine the precise identity
of the oxidation product of arachidonic acid. On the other hand, the mass spectra produced
by electron impact of the products of diverse prostaglandins that apparently eluted at 7.4 min
matched those associated with the 7.4-min peak of the derivatized lipid analyte products of
reactions.
Perhaps the most interesting data in the present study come from an experiment in
which the time course of the production of the 7.4-min analyte was evaluated. At zero time
or 15 min, there was relatively low and constant level of this analyte present in incubations
containing the lipid and Mb, Mb-H, or no protein. After 30 min of incubation, however,
there was a significantly greater level of this analyte in reactions containing Mb or Mb-H.
Interestingly, the level of the analyte in blank samples at 30 min containing the lipid but no
protein was no greater than that detected at zero time. These data indicate that the 7.4-min
analyte requires Mb or Mb-H, although the identity of this as a lipid analyte remains to be
determined.
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4.2 Future Analysis
Future work in this area will need to involve successful verification of the structures
of prostaglandin derivatives and the more complete characterization of the chromatograms to
determine whether relevant peaks are observed beyond the 15-min period established for the
chromatographic conditions. The characterization of arachidonic acid analytes by chemical
derivatization and gas chromatography and mass spectrometry has proven to be quite
difficult in the present study, so alternatively methodologies, perhaps involving the use of
ELISA assays to identify prostaglandin products, will provide a more accurate and less timeconsuming alternative for identification of oxidation products of arachidonic acid.
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APPENDIX A
BSTFA: N,O-bis(trimethylsilyl) trifluoroacetamide
CA: Cholesteryl Arachadonate
EIA: Enzymatic Immunoassay
FOX: Ferrous Oxidation-Xylenol Orange
GC/MS: Gas Chromatography Mass Spectroscopy
GPC: Glycerophosphocholine
HPLC: High Pressure Liquid Chromatography
LCMS: Liquid Chromatography Mass Spectroscopy
LDL: Low Density Lipoprotein
MB: Myoglobin
Mb-H: Myoglobin-H; Myoglobin with protein-bound heme adduct
PAPC: Palmitoyl Arachidonyl Phosphatidylcholine
PGE1: Prostaglandin E1; Prostaglandin with a ketone at position 9, and a hydroxyl at
position 11. The 1 indicates there is 1 double bond.
PGE2α: Prostaglandin E2α; Prostaglandin with a ketone at position 9, and a hydroxyl at
position 11. The 2 indicates there are 2 double bonds; the α indicates there is a
hydroxyl group at position 15 that is oriented behind the plane.
PGF2α: Prostaglandin F2α; Prostaglandin with a hydroxyl at position 9, and a hydroxyl at
position 11. The 2 indicates there are 2 double bonds; the α indicates there is a
hydroxyl group at position 15 that is oriented behind the plane.
PUFA: Poly Unsaturated Fatty Acid
Rf: Retention factor
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ROS: Reactive Oxygen Species; A type of free radical where Oxygen has unpaired electrons
SDS-PAGE: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
TBARS: Thiobarbituric acid reactive substance
TLC: Thin Layer Chromatography
TMSD: Trimethylsilyldiazomethane
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